Peg-interferon alpha induces CD56bright natural killer cell mediated reduction of HBsAg in entecavir treated chronic Hepatitis B patients

被引：0
|
作者：
Shi, Aichao [1 ]
Zhang, Xiaoping [1 ]
Xiao, Fang [1 ]
Yan, Weiming [1 ]
Han, Meifang [1 ]
Chen, Tao [1 ]
Ning, Qin [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
912
引用
收藏
页码：487A / 487A
页数：1
相关论文
共 50 条
  • [1] Dynamic changes of serum hbv pgrna levels in patients with chronic hepatitis B treated with entecavir or peg-interferon
    Yu, Xiaoqi
    Yu, Demin
    Chen, Peizhan
    Gong, Qiming
    Zhang, Xinxin
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E490 - E490
  • [2] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    M. Saraste
    H. Irjala
    L. Airas
    Neurological Sciences, 2007, 28 : 121 - 126
  • [3] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    Saraste, M.
    Irjala, H.
    Airas, L.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 121 - 126
  • [4] CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a
    Shi, A.
    Zhang, X.
    Xiao, F.
    Zhu, L.
    Yan, W.
    Han, M.
    Luo, X.
    Chen, T.
    Ning, Q.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1352 - 1362
  • [5] Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, S.
    Hansen, B.
    Xie, Q.
    Liang, C.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. -P.
    Fehmi, T.
    Campenhout, M. V.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S518 - S519
  • [6] T CELL IMMUNE RESPONSES IN CHRONIC HEPATITIS B PATIENT TREATED WITH PEG-INTERFERON AND ADEFOVIR
    de Niet, Annikki
    Plat-Sinnige, Marjan J. Tempelmans
    Takkenberg, Bart
    Reesink, Hendrik W.
    van Lier, Rene A.
    van Leeuwen, Ester M.
    HEPATOLOGY, 2011, 54 : 1094A - 1095A
  • [7] Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Hadzhiolova-Lebeau, Tanya
    Plavova, Slava
    Katzarov, Krum
    Simonova, Marieta
    Zeuzem, Stephan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    De Knegt, Robert
    Choi, Moon-Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang-Wook
    Chu, Heng-Chen
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth
    Chokshi, Shilpa
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [8] Comparative analysis of Peg-Interferon alpha-2b and lamivudine in the treatment of chronic hepatitis B patients
    Sidiropoulos, I
    Koliouskas, D
    Masmanidou, M
    Mandraveli, K
    Lazaraki, G
    Dokas, S
    Ziakas, A
    HEPATOLOGY, 2002, 36 (04) : 626A - 626A
  • [9] Differential alteration of CD56bright and CD56dim natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
    Miyagi, Takuya
    Shimizu, Satoshi
    Tatsumi, Tomohide
    Nishio, Kumiko
    Hiramatsu, Naoki
    Kanto, Tatsuya
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (08) : 1020 - 1030
  • [10] Differential alteration of CD56bright and CD56dim natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
    Takuya Miyagi
    Satoshi Shimizu
    Tomohide Tatsumi
    Kumiko Nishio
    Naoki Hiramatsu
    Tatsuya Kanto
    Norio Hayashi
    Tetsuo Takehara
    Journal of Gastroenterology, 2011, 46
12345